Last edition
News about "MASH"
Ribo and Madrigal Enter Global Licensing Deal for siRNA Programmes Targeting MASH
Suzhou Ribo Life Science and Madrigal Pharmaceuticals have signed a worldwide licensing agreement covering six pre-clinical siRNA programmes for metabolic dysfunction-associated steatohepatitis, with potential milestone payments of up to USD 4.4 billion.
MASH | 12/02/2026 | By News Bureau | 190
HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care
HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.
MASH | 21/01/2026 | By News Bureau | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy